HKSE - Delayed Quote HKD
IMMUNEONCO-B (1541.HK)
6.440
+0.050
+(0.78%)
At close: May 9 at 4:08:05 PM GMT+8
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Tian (Wenzhi) Chief Executive Officer | Acquisition | Mar 26, 2025 | 85,677,135 |
| Yu (Zhihua) Former | Sale | Nov 13, 2024 | 13,011,440 |
Related Tickers
2157.HK Lepu Biopharma Co., Ltd.
4.490
-3.44%
6955.HK Shandong Boan Biotechnology Co., Ltd.
9.370
-1.78%
1877.HK JUNSHI BIO
14.800
+0.14%
1167.HK JACOBIO-B
3.960
+8.79%
9966.HK Alphamab Oncology
7.340
+2.37%
9995.HK RemeGen Co., Ltd.
37.450
-3.48%
1801.HK INNOVENT BIO
52.400
+1.35%
1672.HK ASCLETIS-B
6.610
-0.90%
9688.HK Zai Lab Limited
23.600
+5.59%
UPB Upstream Bio, Inc.
8.82
-0.23%